Navigation Links
Gene mutation identified for inherited pain syndrome

Researchers have identified the single mutation of the gene involved in causing// the condition of inherited pain syndrome or primary erythromelalgia.

Investigators from Yale School of Medicine have reported in their research findings that the single mutation of the gene for sodium channel Nav1.7 is responsible for people to suffer from the chronic condition of primary erythromelalgia. Researchers have studied the DNA samples from 36 members of a same family in which 17 members suffer from the condition. The genetic mutation makes the pain sensing neurons to be hyper excited and trigger rapids signals even at lower than normal stimulating sensations.

Primary erythromelalgia is a disorder where the symptoms are intense burning pain felt in the hands and feet. The other symptoms of the condition are redness, sensations of heat, and swelling. Anything like standing, walking, exposure to heat may trigger an episode of sudden pain. An inherited condition, erythromelalgia may be only symptomatically treated.

Previous studies have identified two mutations in the gene coding for sodium channel Nav1.7 that is linked with erythromelalgia. The new study identifies the new mutation of the gene responsible. The identification of the mutations of the gene makes it easier to develop treatment for this condition which otherwise had no treatments.

Reference: Brain, July 2005
'"/>




Page: 1

Related medicine news :

1. Minor mutations in HIV virus
2. Genetic mutation to the fountain of youth discovered
3. Success of HIV may depend in its mutations
4. BRAC2 mutations is also linked with cancers in men
5. Familial Breast cancer without gene mutation not found to cause ovarian cancer.
6. Skin Cancer caused by mutations in a single Gene
7. H-ras gene mutation linked to Costello Syndrome
8. Autoimmune disorder caused due to mutation in cryopyrin protein
9. Uterine cancer may be associated with inherited mutations and a risk of many cancers
10. Special proteins to fight TB identified
11. A new growth factor identified
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/27/2017)... Jacksonville, Florida (PRWEB) , ... April 27, 2017 , ... ... qualified candidates. But they will rapidly reject an outdated healthcare executive resume. , “If ... good look at your executive resume and wondering if it’s as ready as you ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... North American CAREGiverSM of the Year for her extraordinary compassion and lifelong dedication ... 60,000 North American professional caregivers for the prestigious award each year – identifying ...
(Date:4/27/2017)... ... ... Offering the purest product of its kind, Swissx Labs AG has launched ... the market has seen before. Swissx uses proprietary strains of hemp plants grown in ... for extraction, to produce its CBD oil--maximizing its benefits for health and wellness. Learn ...
(Date:4/26/2017)... ... April 26, 2017 , ... Jump Technologies, Inc., an ... it has completed a round of funding to accelerate its growth strategies. The ... Granite Capital is a growth equity firm focused on investments in healthcare and ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... to announce the ATA 2017 President’s Awards recipients, comprised of organizations and ... healthcare delivery. , The ATA 2017 President’s Awards recognize individuals and ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will participate ... the Sheraton Hotel in Toronto, Ontario . ... is scheduled to present on Tuesday, May 2 at 10:00 am. ... the Board, Tony Holler will also attend the event. ... For more details about the ...
(Date:4/19/2017)... Global Surgical Drainage Device Market: Overview ... remove excess liquid and air. The fluid to be ... lymph. Surgical drains are used in a wide variety ... cardiovascular surgery, neurosurgery, plastic surgery etc. Common use of ... of fluid e.g. blood or pus. Surgical drains are ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
Breaking Medicine Technology: